Germany / Nepal / Peru / United States / United Kingdom / India / / /
Event
FDA Phase / Judicial Event / /
Facility
University of Hamburg / Institute of Hygiene / University Hospital Goettingen / University of Goettingen / /
IndustryTerm
pharmaceutical company screening programme / treatment of cutaneous metastases in breast cancer / lipid chemical mediators / pharmaceutical industry / cancer therapy / Cancer Treat / miltefosine solution / treatment of cutaneous breast cancer / treatment of breast cancer / /
MedicalCondition
solid tumours / HIV / cutaneous breast cancer / established Leishmania infantum infection / Leishmaniasis / experimental cutaneous leishmaniasis / breast cancer / cutaneous disease / mammary carcinoma / murine Leishmania donovani infection / immunodeficient scid / cutaneous metastases / cancer / disease / advanced solid tumors / J. Cancer / tumour / experimental visceral leishmaniasis / breast cancer skin metastases / visceral and cutaneous leishmaniasis / scid / cutaneous leishmaniasis / Tropical Diseases / infection / visceral leishmaniasis / /
MedicalTreatment
chemotherapy / cancer therapy / /
NaturalFeature
ALPs / /
Organization
World Health Organization / TDR / Royal Society of Tropical Medicine and Hygiene / Institute for Biophysical Chemistry / World Bank / Indian Government / Department of Biochemistry / University of Hamburg / /
Person
Kim / Breiser / Simon L. Croft / Hanahan / Bill Pendergast / Joseph Chan / Pinckard / / /
Position
D.J. / Corresponding author / R.N. / /
Product
allopurinol / AmBisome / amphotericin B / India / Miltex® / miltefosine / Europe / /
ProgrammingLanguage
EC / /
ProvinceOrState
New York / /
Technology
cloning / PDF / chemotherapy / treating cancer / /
doi:j.trstmh